Percorrendo por Autor WERUTSKY, GUSTAVO
Mostrando regs. 1 a 4 de 4
Data de publicação | Título | Autor(es) |
2021 | A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415) | MALUF, FERNANDO C.; SCHUTZ, FABIO A.; CRONEMBERGER, EDUARDO H., et al |
2019 | PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114) | WERUTSKY, GUSTAVO; Bruno Hochhegger; LOPES DE FIGUEIREDO PINTO, JOSÉ ANTÔNIO, et al |
2019 | PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114) | WERUTSKY, GUSTAVO; Bruno Hochhegger; LOPES DE FIGUEIREDO PINTO, JOSÉ ANTÔNIO, et al |
2019 | The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels | WERUTSKY, GUSTAVO; MALUF, FERNANDO COTAIT; CRONEMBERGER, EDUARDO HENRIQUE, et al |